Compare TLX & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | FG |
|---|---|---|
| Founded | 2015 | 1959 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | TLX | FG |
|---|---|---|
| Price | $7.76 | $27.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $21.00 | ★ $41.00 |
| AVG Volume (30 Days) | 190.3K | ★ 1.1M |
| Earning Date | 01-19-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | N/A | ★ 3428.12 |
| EPS | 0.04 | ★ 3.42 |
| Revenue | $664,225,558.00 | ★ $5,559,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.46 |
| P/E Ratio | $239.61 | ★ $8.04 |
| Revenue Growth | ★ 55.35 | N/A |
| 52 Week Low | $7.31 | $27.11 |
| 52 Week High | $30.36 | $47.76 |
| Indicator | TLX | FG |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 31.00 |
| Support Level | $7.42 | $27.11 |
| Resistance Level | $7.71 | $27.98 |
| Average True Range (ATR) | 0.15 | 1.08 |
| MACD | 0.07 | -0.29 |
| Stochastic Oscillator | 70.31 | 6.02 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.